Bausch Health Companies (BHC) Share-based Compensation (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Share-based Compensation came in at $52.0 million in Q1 2026, up 20.93% year-on-year from $43.0 million in Q1 2025, and down 38.1% quarter-over-quarter from $84.0 million in Q4 2025.
Bausch Health Companies (BHC) Share-based Compensation (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Share-based Compensation across 18 years of filings, most recently posting $52.0 million for Q1 2026.
- Share-based Compensation for Q1 2026 came in at $52.0 million, up 20.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $225.0 million (up 40.62% YoY), and the FY2025 annual result was $216.0 million, up 44.0% from the prior year.
- Share-based Compensation came in at $52.0 million for Q1 2026 at Bausch Health Companies, down from $84.0 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $84.0 million in Q4 2025 to a low of $26.0 million in Q2 2022.
- The 5-year median for Share-based Compensation is $36.0 million (2024), against an average of $39.8 million.
- Across the five-year window, Share-based Compensation dropped 19.51% in 2024 and surged 95.35% in 2025, its largest moves.
- Bausch Health Companies' Share-based Compensation stood at $35.0 million in 2022, then decreased by 17.14% to $29.0 million in 2023, then surged by 48.28% to $43.0 million in 2024, then jumped by 95.35% to $84.0 million in 2025, then tumbled by 38.1% to $52.0 million in 2026.
- The last three Share-based Compensation figures came in at $52.0 million (Q1 2026), $84.0 million (Q4 2025), and $43.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 36.86 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.04 Mn |
| 10 | Bausch Health Companies | 1.93 Bn | 1.59 Bn | 2.48 Bn | 52.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.00 Mn |
| Mar 31, 2026 | 52.00 Mn |
| Dec 31, 2025 | 84.00 Mn |
| Dec 31, 2025 | 84.00 Mn |
| Sep 30, 2025 | 43.00 Mn |
| Sep 30, 2025 | 43.00 Mn |
| Jun 30, 2025 | 46.00 Mn |
| Jun 30, 2025 | 46.00 Mn |
| Mar 31, 2025 | 43.00 Mn |
| Mar 31, 2025 | 43.00 Mn |
| Dec 31, 2024 | 43.00 Mn |
| Dec 31, 2024 | 43.00 Mn |
| Sep 30, 2024 | 38.00 Mn |
| Sep 30, 2024 | 38.00 Mn |
| Jun 30, 2024 | 36.00 Mn |
| Jun 30, 2024 | 36.00 Mn |
| Mar 31, 2024 | 33.00 Mn |
| Mar 31, 2024 | 33.00 Mn |
| Dec 31, 2023 | 29.00 Mn |
| Dec 31, 2023 | 29.00 Mn |